Bernard I. Dentz

Array ( [id] => 638010 [patent_doc_number] => 07125965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'MRI probes of membrane potential' [patent_app_type] => utility [patent_app_number] => 10/700712 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 7235 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125965.pdf [firstpage_image] =>[orig_patent_app_number] => 10700712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760819 [patent_doc_number] => 20060211764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Cell activator, process for producing cell activator and apparatus therefor' [patent_app_type] => utility [patent_app_number] => 10/533360 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7365 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211764.pdf [firstpage_image] =>[orig_patent_app_number] => 10533360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7292035 [patent_doc_number] => 20040110973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Olefin oxide catalysts' [patent_app_type] => new [patent_app_number] => 10/695357 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6444 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110973.pdf [firstpage_image] =>[orig_patent_app_number] => 10695357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338340 [patent_doc_number] => 20040133018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Process for producing propylene oxide' [patent_app_type] => new [patent_app_number] => 10/475998 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2102 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20040133018.pdf [firstpage_image] =>[orig_patent_app_number] => 10475998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7241537 [patent_doc_number] => 20040158081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Continuous process for the preparation of fructopyranose sulfamate derivatives' [patent_app_type] => new [patent_app_number] => 10/691782 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9710 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20040158081.pdf [firstpage_image] =>[orig_patent_app_number] => 10691782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991415 [patent_doc_number] => 20050090452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae' [patent_app_type] => utility [patent_app_number] => 10/690914 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10996 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090452.pdf [firstpage_image] =>[orig_patent_app_number] => 10690914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991415 [patent_doc_number] => 20050090452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae' [patent_app_type] => utility [patent_app_number] => 10/690914 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10996 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090452.pdf [firstpage_image] =>[orig_patent_app_number] => 10690914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002546 [patent_doc_number] => 06909002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Method of preparing inhibitors of phosphodiesterase-4' [patent_app_type] => utility [patent_app_number] => 10/690118 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28694 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/909/06909002.pdf [firstpage_image] =>[orig_patent_app_number] => 10690118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7209239 [patent_doc_number] => 20040087804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Process for producing epsilon-caprolactone' [patent_app_type] => new [patent_app_number] => 10/688926 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4963 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087804.pdf [firstpage_image] =>[orig_patent_app_number] => 10688926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1116620 [patent_doc_number] => 06800785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-05 [patent_title] => 'Process for the synthesis of estrogen receptor modulators' [patent_app_type] => B1 [patent_app_number] => 10/685719 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6315 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 554 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800785.pdf [firstpage_image] =>[orig_patent_app_number] => 10685719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387143 [patent_doc_number] => 20040082648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Antibiotic cytosporacin' [patent_app_type] => new [patent_app_number] => 10/684546 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3220 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082648.pdf [firstpage_image] =>[orig_patent_app_number] => 10684546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1086175 [patent_doc_number] => 06831179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-14 [patent_title] => 'Process for the stereoselective preparation of insecticide 6,7,8,9,10-10-hexahalo-1,5,5a,6,9,9a-hexadro-6,9-methano-2,4,3-benzodioxathiepin-3-oxide' [patent_app_type] => B2 [patent_app_number] => 10/474029 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3607 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/831/06831179.pdf [firstpage_image] =>[orig_patent_app_number] => 10474029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946637 [patent_doc_number] => 06964971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => '1,6-naphthyridine derivatives and their use to treat diabetes and related disorders' [patent_app_type] => utility [patent_app_number] => 10/684299 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41610 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3945 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/964/06964971.pdf [firstpage_image] =>[orig_patent_app_number] => 10684299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338344 [patent_doc_number] => 20040133019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Catalyst for the oxidation of hydrocarbons to epoxides' [patent_app_type] => new [patent_app_number] => 10/683741 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6854 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20040133019.pdf [firstpage_image] =>[orig_patent_app_number] => 10683741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674600 [patent_doc_number] => 20040127518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Modulation of anxiety through blockade of anandamide hydrolysis' [patent_app_type] => new [patent_app_number] => 10/681858 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32435 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127518.pdf [firstpage_image] =>[orig_patent_app_number] => 10681858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691133 [patent_doc_number] => 07074826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'R-NSAID esters and their use' [patent_app_type] => utility [patent_app_number] => 10/678430 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11786 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074826.pdf [firstpage_image] =>[orig_patent_app_number] => 10678430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325602 [patent_doc_number] => 20040138297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Agent for lowering prolactin' [patent_app_type] => new [patent_app_number] => 10/676314 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2338 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138297.pdf [firstpage_image] =>[orig_patent_app_number] => 10676314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754072 [patent_doc_number] => 07018818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Intermediates in the preparation of therapeutic fused bicyclic amino acids' [patent_app_type] => utility [patent_app_number] => 10/677836 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5792 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018818.pdf [firstpage_image] =>[orig_patent_app_number] => 10677836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7628065 [patent_doc_number] => 06806371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-19 [patent_title] => 'Preparation of substituted pyridine N-oxide compounds' [patent_app_type] => B2 [patent_app_number] => 10/674524 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3150 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806371.pdf [firstpage_image] =>[orig_patent_app_number] => 10674524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606622 [patent_doc_number] => 07153987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Process for making silver based epoxidation catalysts and process for preparing an olefin oxide' [patent_app_type] => utility [patent_app_number] => 10/677647 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5928 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153987.pdf [firstpage_image] =>[orig_patent_app_number] => 10677647 [rel_patent_id] =>[rel_patent_doc_number] =>)